XML 94 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities    
Net loss $ (22,593,628) $ (6,659,899)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,054,996 1,302,384
Bad debt recovery (84,377) (143,774)
Impairment expense 4,720,624 0
Loss on shares issued in settlement of consulting agreement 152,629 0
Gain or loss on debt settlement 8,521,149 0
Equity based compensation expense 5,614,919 1,490,903
Change in fair value of warrant liability (13,459) (96,000)
Loss on adjustment of fair value of marketable securities 239,869 170,383
Gain on assets sale (1,763,430) (552,527)
Amortization of debt discount and debt costs 177,072 1,346,280
Loss on loan amendment 0 193,355
Factoring discount fee and interest 0 22,009
Changes in assets and liabilities:    
Decrease in accounts receivable 457,958 1,967,824
(Increase) decrease in prepaid expenses and other current assets (207,193) 95,623
Decrease in accounts payable and accrued liabilities (320,192) (18,489)
Decrease in deferred revenue (54,452) (65,371)
Net cash used in operating activities (4,097,515) (947,299)
Cash Flows from Investing Activities:    
Proceeds from sale of assets 1,763,430 0
Net cash provided by investing activities 1,763,430 0
Cash Flows from Financing Activities:    
Issuance of common stock, net of fees 4,330,975 785,509
Repayments of notes (1,071,552) (668,478)
Gross proceeds from exercise of the warrants 599,244 315,178
Proceeds from ERC advances 0 450,000
Repayment of ERC advances 0 (450,000)
Proceeds from factoring agreement 0 871,821
Repayments of factoring agreement 0 (215,127)
Purchase of preferred shares pursuant to recapitalization 0 (80,000)
Net cash provided by financing activities 3,858,667 1,008,903
Net increase in cash 1,524,582 61,604
Cash, beginning of year 1,008,408 946,804
Cash, end of year 2,532,990 1,008,408
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 150,461 323,141
Cash paid during the year for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Issuance of common stock issued upon purchase of intangible assets 647,055 0
Warrants issued in connection with purchase of intangible assets 480,358 0
Issuance of common stock issued upon conversion of note payable 273,673 0
Issuance of common stock from conversion of Preferred stock, Series E 9 0
Issuance of common stock from conversion of warrants 592,056 0
Issuance of common stock for debt settlements 2,705,717 0
Accounts receivable owed under factoring agreement collected directly by factor 0 959,980
Deemed dividends 0 503,642
Offering costs as a result of modification of warrants to induce exercise 0 10,400
Financing of insurance premium 0 92,174
Debt discount on loan amendment 0 50,000
Transfer of accrued interest to loan principal upon loan amendment $ 0 $ 80,555